Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation

Comprehending the molecular mechanisms underlying hepatic fibrogenesis is essential to the development of treatment. The hallmark of hepatic fibrosis is the development and deposition of excess fibrous connective tissue forcing tissue remodeling. Hepatic stellate cells (HSC) play a major role in the pathogenesis of liver fibrosis. Their activation via the transforming growth factor-beta 1 (TGF-beta 1) as a key mediator is considered the crucial event in the pathophysiology of hepatic fibrogenesis. It has been shown that Perilipin 5 (PLIN5), known as a lipid droplet structural protein that is highly expressed in oxidative tissue, can inhibit such activation through various mechanisms associated with lipid metabolism. This study aimed to investigate the possible influence of PLIN5 on TGF-beta 1 signaling. Our findings confirm the importance of PLIN5 in maintaining HSC quiescence in vivo and in vitro. PLIN5 overexpression suppresses the TGF-beta 1-SMAD2/3 and SNAIL signaling pathways as well as the activation of the signal transducers and activators of transcription 3 (STAT3). These findings derived from experiments in hepatic cell lines LX-2 and Col-GFP, in which overexpression of PLIN5 was able to downregulate the signaling pathways SMAD2/3 and SNAIL activated previously by TGF-beta 1 treatment. Furthermore, TGF-beta 1-mediatedinduction of extracellular matrix proteins, such as collagen type I (COL1), Fibronectin, and alpha-smooth muscle actin (alpha-SMA), was suppressed by PLIN5. Moreover, STAT3, which is interrelated with TGF-beta 1 was already basally activated in the cell lines and inhibited by PLIN5 overexpression, leading to a further reduction in HSC activity shown by lowered alpha-SMA expression. This extension of the intervening mechanisms presents PLIN5 as a potent and pleiotropic target in HSC activation.

Automated summary

Understanding the molecular mechanisms of hepatic fibrogenesis is crucial for treatment development, with hepatic stellate cells (HSC) and Perilipin 5 (PLIN5) playing important roles in the pathophysiology. PLIN5 overexpression inhibits HSC activation by suppressing TGF-β1 signaling pathways, indicating its potential as a therapeutic target.